BIOMAT Database Logo BIOMAT Database Logo

Gene expression analysis of head and neck squamous cell carcinoma survival and recurrence. 2015

Xu Zhi, and Katarzyna Lamperska, and Paweł Golusinski, and Nicholas J Schork, and Lukasz Luczewski, and Tomasz Kolenda, and Wojciech Golusinski, and Michal M Masternak
Department of Obstetrics and Gynecology, Center for Reproductive Medicine, Peking University Third Hospital, Beijing, China. College of Medicine, Burnett School of Biomedical Sciences, University of Central Florida, Orlando, FL, USA.

The squamous cell carcinomas represent about 90 % of all head and neck cancers, ranking the sixth most common human cancer. Approximately 450,000 of new cases of head and neck squamous cell carcinoma (HNSCC) are diagnosed every year. Unfortunately, because of diagnosis at the advanced stages and early metastasis to the lymph nodes, the HNSCC is associated with very high death rate. Identification of signature biomarkers and molecularly targeted therapies could provide more effective and specific cancer treatment, prevent recurrence, and increase survival rate. We used paired tumor and adjacent normal tissue samples to screen with RT² Profiler™ PCR Array Human Cancer PathwayFinderTM . Total of 20 up-regulated genes and two down-regulated genes were screened out. Out of 22 genes, 12 genes were subsequently validated to be significantly altered in the HNSCC; the samples were from all 41 patients. Five year survival and recurrence selected genes that could represent the biomarkers of survival and recurrence of the disease. We believe that comprehensive understanding of the unique genetic characteristics of HNSCC could provide novel diagnostic biomarkers and meet the requirement for molecular-targeted therapy for the HNSCC.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D002294 Carcinoma, Squamous Cell A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed) Carcinoma, Epidermoid,Carcinoma, Planocellular,Carcinoma, Squamous,Squamous Cell Carcinoma,Carcinomas, Epidermoid,Carcinomas, Planocellular,Carcinomas, Squamous,Carcinomas, Squamous Cell,Epidermoid Carcinoma,Epidermoid Carcinomas,Planocellular Carcinoma,Planocellular Carcinomas,Squamous Carcinoma,Squamous Carcinomas,Squamous Cell Carcinomas
D005260 Female Females
D006258 Head and Neck Neoplasms Soft tissue tumors or cancer arising from the mucosal surfaces of the LIP; oral cavity; PHARYNX; LARYNX; and cervical esophagus. Other sites included are the NOSE and PARANASAL SINUSES; SALIVARY GLANDS; THYROID GLAND and PARATHYROID GLANDS; and MELANOMA and non-melanoma skin cancers of the head and neck. (from Holland et al., Cancer Medicine, 4th ed, p1651) Cancer of Head and Neck,Head Cancer,Head Neoplasm,Head and Neck Cancer,Head and Neck Neoplasm,Neck Cancer,Neck Neoplasm,Neck Neoplasms,Neoplasms, Upper Aerodigestive Tract,UADT Neoplasm,Upper Aerodigestive Tract Neoplasm,Upper Aerodigestive Tract Neoplasms,Cancer of Head,Cancer of Neck,Cancer of the Head,Cancer of the Head and Neck,Cancer of the Neck,Head Neoplasms,Head, Neck Neoplasms,Neoplasms, Head,Neoplasms, Head and Neck,Neoplasms, Neck,UADT Neoplasms,Cancer, Head,Cancer, Neck,Cancers, Head,Cancers, Neck,Head Cancers,Neck Cancers,Neoplasm, Head,Neoplasm, Neck,Neoplasm, UADT,Neoplasms, UADT
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077195 Squamous Cell Carcinoma of Head and Neck The most common type of head and neck carcinoma that originates from cells on the surface of the NASAL CAVITY; MOUTH; PARANASAL SINUSES, SALIVARY GLANDS, and LARYNX. Mutations in TNFRSF10B, PTEN, and ING1 genes are associated with this cancer. HNSCC,Head And Neck Squamous Cell Carcinomas,Hypopharyngeal Squamous Cell Carcinoma,Laryngeal Squamous Cell Carcinoma,Oral Cavity Squamous Cell Carcinoma,Oral Squamous Cell Carcinoma,Oral Squamous Cell Carcinomas,Oral Tongue Squamous Cell Carcinoma,Oropharyngeal Squamous Cell Carcinoma,Squamous Cell Carcinoma of Larynx,Squamous Cell Carcinoma of the Larynx,Squamous Cell Carcinoma of the Mouth,Squamous Cell Carcinoma of the Nasal Cavity,Carcinoma, Squamous Cell of Head and Neck,Head and Neck Squamous Cell Carcinoma,Squamous Cell Carcinoma of the Head and Neck,Squamous Cell Carcinoma, Head And Neck
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

Xu Zhi, and Katarzyna Lamperska, and Paweł Golusinski, and Nicholas J Schork, and Lukasz Luczewski, and Tomasz Kolenda, and Wojciech Golusinski, and Michal M Masternak
Expression of haptoglobin predicts recurrence in head and neck squamous cell carcinoma.
August 2010, Clinica chimica acta; international journal of clinical chemistry,
Xu Zhi, and Katarzyna Lamperska, and Paweł Golusinski, and Nicholas J Schork, and Lukasz Luczewski, and Tomasz Kolenda, and Wojciech Golusinski, and Michal M Masternak
Differential gene expression and network analysis in head and neck squamous cell carcinoma.
May 2022, Molecular and cellular biochemistry,
Xu Zhi, and Katarzyna Lamperska, and Paweł Golusinski, and Nicholas J Schork, and Lukasz Luczewski, and Tomasz Kolenda, and Wojciech Golusinski, and Michal M Masternak
Gene expression profiling in head and neck squamous cell carcinoma.
April 2010, Current opinion in otolaryngology & head and neck surgery,
Xu Zhi, and Katarzyna Lamperska, and Paweł Golusinski, and Nicholas J Schork, and Lukasz Luczewski, and Tomasz Kolenda, and Wojciech Golusinski, and Michal M Masternak
Recurrence in head and neck squamous cell carcinoma. Editorial.
August 2008, Cancer,
Xu Zhi, and Katarzyna Lamperska, and Paweł Golusinski, and Nicholas J Schork, and Lukasz Luczewski, and Tomasz Kolenda, and Wojciech Golusinski, and Michal M Masternak
Analysis of cytokine gene expression in squamous cell carcinoma of the head and neck.
January 1996, International journal of oncology,
Xu Zhi, and Katarzyna Lamperska, and Paweł Golusinski, and Nicholas J Schork, and Lukasz Luczewski, and Tomasz Kolenda, and Wojciech Golusinski, and Michal M Masternak
Immune gene expression in head and neck squamous cell carcinoma patients.
November 2019, European journal of cancer (Oxford, England : 1990),
Xu Zhi, and Katarzyna Lamperska, and Paweł Golusinski, and Nicholas J Schork, and Lukasz Luczewski, and Tomasz Kolenda, and Wojciech Golusinski, and Michal M Masternak
Analysis of gene amplification in head-and-neck squamous-cell carcinoma.
June 1991, International journal of cancer,
Xu Zhi, and Katarzyna Lamperska, and Paweł Golusinski, and Nicholas J Schork, and Lukasz Luczewski, and Tomasz Kolenda, and Wojciech Golusinski, and Michal M Masternak
Expression profile analysis identifies a two-gene signature for prediction of head and neck squamous cell carcinoma patient survival.
January 2018, Journal of cancer research and therapeutics,
Xu Zhi, and Katarzyna Lamperska, and Paweł Golusinski, and Nicholas J Schork, and Lukasz Luczewski, and Tomasz Kolenda, and Wojciech Golusinski, and Michal M Masternak
Comprehensive gene expression meta-analysis of head and neck squamous cell carcinoma microarray data defines a robust survival predictor.
August 2014, Annals of oncology : official journal of the European Society for Medical Oncology,
Xu Zhi, and Katarzyna Lamperska, and Paweł Golusinski, and Nicholas J Schork, and Lukasz Luczewski, and Tomasz Kolenda, and Wojciech Golusinski, and Michal M Masternak
Gene-expression signature predicts survival benefit from postoperative chemoradiotherapy in head and neck squamous cell carcinoma.
August 2018, Oncology letters,
Copied contents to your clipboard!